MedTrace Logo

ABM for ACO Beneficiaries

NCT02137551 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 595

Last updated 2016-02-10

No results posted yet for this study

Summary

The primary objective of the study is to evaluate how engaging ACO beneficiaries in the appointment based model for one year impacts medication adherence and healthcare costs compared to usual care.

Conditions

  • Medication Adherence

Interventions

OTHER

ABM

The ABM involves synchronizing all medications to come due on the same say of the month and the individual receives a pre-appointment phone call from the pharmacy staff to review medications and identify any changes.

Sponsors & Collaborators

  • American Pharmacists Association Foundation

    lead OTHER

Principal Investigators

  • Lindsay Kunkle, PharmD · APhA

  • Benjamin Bluml, BPharm · APhA Foundation

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-11-30
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02137551 on ClinicalTrials.gov